162 related articles for article (PubMed ID: 12383878)
1. Increased expression of renal neutral endopeptidase in severe heart failure.
Knecht M; Pagel I; Langenickel T; Philipp S; Scheuermann-Freestone M; Willnow T; Bruemmer D; Graf K; Dietz R; Willenbrock R
Life Sci; 2002 Oct; 71(23):2701-12. PubMed ID: 12383878
[TBL] [Abstract][Full Text] [Related]
2. Renal response to acute neutral endopeptidase inhibition in mild and severe experimental heart failure.
Chen HH; Schirger JA; Chau WL; Jougasaki M; Lisy O; Redfield MM; Barclay PT; Burnett JC
Circulation; 1999 Dec; 100(24):2443-8. PubMed ID: 10595958
[TBL] [Abstract][Full Text] [Related]
3. The role of neutral endopeptidase in dogs with evolving congestive heart failure.
Margulies KB; Barclay PL; Burnett JC
Circulation; 1995 Apr; 91(7):2036-42. PubMed ID: 7895362
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment with neutral endopeptidase inhibitor improves cardiac function and reduces natriuretic peptides in rats with chronic heart failure.
Maki T; Nasa Y; Yamaguchi F; Yoshida H; Mori M; Takada T; Horikawa E; Okano K; Takeo S
Cardiovasc Res; 2001 Aug; 51(3):608-17. PubMed ID: 11476752
[TBL] [Abstract][Full Text] [Related]
5. Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt.
Willenbrock R; Scheuermann M; Höhnel K; Luft FC; Dietz R
Hypertension; 1996 Jun; 27(6):1259-66. PubMed ID: 8641733
[TBL] [Abstract][Full Text] [Related]
6. Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure.
Martin FL; Stevens TL; Cataliotti A; Schirger JA; Borgeson DD; Redfield MM; Luchner A; Burnett JC
Kidney Int; 2005 May; 67(5):1723-30. PubMed ID: 15840018
[TBL] [Abstract][Full Text] [Related]
7. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
Wegner M; Hirth-Dietrich C; Stasch JP
Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure.
Abassi ZA; Kotob S; Golomb E; Pieruzzi F; Keiser HR
Hypertension; 1995 Jun; 25(6):1178-84. PubMed ID: 7768560
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin inhibition and atrial natriuretic peptide release after acute volume expansion in rats with aortocaval shunt.
Willenbrock R; Scheuermann M; Thibault G; Haass M; Höhnel K; Bohlender J; Luft FC; Dietz R
Cardiovasc Res; 1999 Jun; 42(3):733-42. PubMed ID: 10533614
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of the therapeutic effect of astragalus membranaceus on sodium and water retention in experimental heart failure.
Ma J; Peng A; Lin S
Chin Med J (Engl); 1998 Jan; 111(1):17-23. PubMed ID: 10322646
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of natriuretic peptides by neutral endopeptidase inhibitors.
Seymour AA; Abboa-Offei BE; Smith PL; Mathers PD; Asaad MM; Rogers WL
Clin Exp Pharmacol Physiol; 1995 Jan; 22(1):63-9. PubMed ID: 7768036
[TBL] [Abstract][Full Text] [Related]
12. Effect of neutral endopeptidase inhibitor in rats with congestive heart failure.
Murohara Y; Johnston CI
Clin Exp Pharmacol Physiol; 1992 May; 19(5):380-3. PubMed ID: 1325886
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin gene-related peptide is not elevated in rat plasma by heart failure or by neutral endopeptidase inhibition.
Helin K; Tikkanen I; Kiilavuori K; Näveri H; Fyhrquist F
Life Sci; 1994; 55(6):471-7. PubMed ID: 8035665
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure.
Margulies KB; Perrella MA; McKinley LJ; Burnett JC
J Clin Invest; 1991 Nov; 88(5):1636-42. PubMed ID: 1658047
[TBL] [Abstract][Full Text] [Related]
15. Elevation of plasma atrial natriuretic peptide in rats with chronic heart failure by SCH 39370, a neutral metalloendopeptidase inhibitor.
Tikkanen I; Helin K; Tikkanen T; Sybertz EJ; Vemulapalli S; Sariola H; Näveri H; Fyhrquist F
J Pharmacol Exp Ther; 1990 Aug; 254(2):641-5. PubMed ID: 2143536
[TBL] [Abstract][Full Text] [Related]
16. Concurrent neutral endopeptidase and ACE inhibition in experimental heart failure: renal and hormonal effects.
Helin K
Scand J Clin Lab Invest; 1993 Dec; 53(8):843-51. PubMed ID: 8140395
[TBL] [Abstract][Full Text] [Related]
17. Prolonged neutral endopeptidase inhibition in heart failure.
Helin K; Tikkanen I; Tikkanen T; Saijonmaa O; Sybertz EJ; Vemulapalli S; Sariola H; Fyhrquist F
Eur J Pharmacol; 1991 May; 198(1):23-30. PubMed ID: 1655477
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase-5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide-mediated lipolysis.
Moro C; Klimcakova E; Lafontan M; Berlan M; Galitzky J
Br J Pharmacol; 2007 Dec; 152(7):1102-10. PubMed ID: 17906676
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids improve renal responsiveness to atrial natriuretic peptide by up-regulating natriuretic peptide receptor-A expression in the renal inner medullary collecting duct in decompensated heart failure.
Liu C; Chen Y; Kang Y; Ni Z; Xiu H; Guan J; Liu K
J Pharmacol Exp Ther; 2011 Oct; 339(1):203-9. PubMed ID: 21737535
[TBL] [Abstract][Full Text] [Related]
20. [Functional compartmentation of the endocrine action of cardiac natriuretic peptides].
Haloui M; Arnal JF; Pham I; Gonzalez W; Lyoussi B; Michel JB
Ann Endocrinol (Paris); 2000 Feb; 61(1):32-40. PubMed ID: 10790590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
